Le Lézard
Classified in: Health
Subjects: AWD, DIS, DEI

The American Council of the Blind's 2023 Audio Description People's Choice Award


ALEXANDRIA, Va., Aug. 1, 2023 /PRNewswire/ -- The American Council of the Blind (ACB) announces that the 2023 Audio Description People's Choice Award finalist vote is open through August 15th. The winners will be revealed during the 2023 ACB Audio Description Awards Gala, which will take place virtually on November 14th at 7:30 p.m. Eastern.

The American Council of the Blind announces that the Audio Description People's Choice Award finalist vote is now open. 

ACB's Audio Description Awards Gala celebrates outstanding achievements in audio description in media and recognizes the commitment to accessible entertainment demonstrated by television networks, streaming services, and the film industry. The Audio Description People's Choice Award, now in its second year, is a unique opportunity for fans to get involved by showing their support for the audio description they love the most.

Five Audio Description People's Choice Award finalists in each category (films and series) have been chosen to compete for the 2023 award. The finalists represent the top titles selected through an open nomination process that took place in June.  

The finalists are:

Films:
Top Gun: Maverick
Everything Everywhere All at Once
Little Mermaid (Live Action)
Flamin' Hot
Emergency

Series:
Stranger Things
Better Call Saul
Alma's Way
Wednesday
Star Trek: Picard

To find samples with audio description for each finalist, visit www.acb.org/2023-AD-Peoples-Choice.

Voting for the Audio Description People's Choice Award ends on Tuesday, August 15th at 11:59 p.m. Eastern. To cast your vote, visit www.surveymonkey.com/r/2023AD-Peoples-Choice. To vote by phone, call (202) 596-7041.

Join us on November 14th at 7:30 p.m. Eastern as we announce the Audio Description People's Choice Award winners at the 2023 Audio Description Awards Gala. Learn more at www.ADAwardsGala.org.

About the American Council of the Blind

The American Council of the Blind is a national member-driven organization representing Americans who are blind or have low vision. For more than 60 years, ACB has been a leader in national, state, local, and international advocacy efforts. With 68 affiliates, ACB strives to increase independence, security, equality of opportunity, and the quality of life for all people who are blind or have low vision. For more information, visit www.acb.org.

SOURCE American Council of the Blind


These press releases may also interest you

at 14:06
Red Door Community Raises more than $300,000 at Their Annual Luncheon Celebrating Women Working and Living with Cancer
On Wednesday, May 15, Red Door Community hosted their annual Celebrating Women Working and Living with Cancer Luncheon at the Metropolitan Club in New York City. The event raised more than $300,000 while shining a light on the women who inspire us...

at 14:05
Easy Eats Pandemanila brand Kalihim (Philippine Bread Rolls) recalled due to undeclared egg
Product: Kalihim (Philippine Bread Roll) Issue: Food - Allergen - Egg Distribution: British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

at 13:27
Industrial Automation Market In Life Sciences Industry size is set to grow by USD 5.06 bn from 2024-2028, growing global demand for healthcare services to boost the market growth, Technavio
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

at 11:03
MODULAR ATP Study of the mCRMtm System Meets Primary Safety and Efficacy Endpoints
Boston Scientific Corporation today announced positive six-month results from the ongoing pivotal MODULAR ATP clinical trial of the mCRMtm System,* the first modular cardiac rhythm management (CRM) system that consists of the EMBLEMtm Subcutaneous...

at 08:35
Investigational Seladelpar Demonstrates Significant Improvements in Liver Disease Progression and Reduced Itching in Primary Biliary Cholangitis
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

at 07:05
Mirum Pharmaceuticals' LIVMARLI Data Showcased at ESPGHAN Annual Meeting
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...

More news about Health...


News published on and distributed by: